Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 26 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine usersMcKetin, R.; Gardner, J.; Baker, A.; Dawe, S.; Ali, R.; Voce, A.; Leach, L.; Lubman, D.; Australasian Professional Society on Alcohol and other Drugs Conference 2016 (30 Oct 2016 - 2 Nov 2016 : Sydney, Australia)
2016Psychosocial interventions for cannabis use disorderGates, P.; Sabioni, P.; Copeland, J.; Le Foll, B.; Gowing, L.; Australasian Professional Society on Alcohol and other Drugs Conference 2016 (30 Oct 2016 - 2 Nov 2016 : Sydney, Australia)
2016Sequence symmetry analysis as a signal detection tool for potential heart failure adverse events in an administrative claims databaseWahab, I.A.; Pratt, N.L.; Ellett, L.K.; Roughead, E.E.
2016Authors’ reply to Palozzo and Messori: ‘‘Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review’’Parkinson, B.; Elshaug, A.G.
2016Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalitiesPhilpott, H.; Nandurkar, S.; Royce, S.; Thien, F.; Gibson, P.
2016A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitisPhilpott, H.; Nandurkar, S.; Royce, S.; Thien, F.; Gibson, P.
2016Therapeutic drug monitoring of everolimus: a consensus reportShipkova, M.; Hesselink, D.; Holt, D.; Billaud, E.; Van Gelder, T.; Kunicki, P.; Brunet, M.; Budde, K.; Barten, M.; De Simone, P.; Wieland, E.; Lopez, O.; Masuda, S.; Seger, C.; Picard, N.; Oellerich, M.; Langman, L.; Wallemacq, P.; Morris, R.; Thompson, C.; et al.
2016Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aortaNg, H.H.; Leo, C.H.; Parry, L.J.
2016Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depressionLoo, C.; Gálvez, V.; O'Keefe, E.; Mitchell, P.; Hadzi-Pavlovic, D.; Leyden, J.; Harper, S.; Somogyi, A.; Lai, R.; Weickert, C.; Glue, P.
2016Diversion and injection of buprenorphine-naloxone film two years post-introduction in AustraliaLarance, B.; Mattick, R.; Ali, R.; Lintzeris, N.; Jenkinson, R.; White, N.; Kihas, I.; Cassidy, R.; Degenhardt, L.; Wilkinson, C.; Livingston, M.